Non-expressing homozygous C282Y carriers and haemochromatosis
BMJ 2024; 387 doi: https://doi.org/10.1136/bmj.q2704 (Published 09 December 2024) Cite this as: BMJ 2024;387:q2704Linked Research
Mortality and risk of diabetes, liver disease, and heart disease in individuals with haemochromatosis HFE C282Y homozygosity and normal concentrations of iron, transferrin saturation, or ferritin
- Paul C Adams, professor emeritus
- Department of Medicine, Western University, London, ON, Canada
- padams{at}uwo.ca
After the detailed description of 311 patients with iron overload by J H Sheldon in 1935,1 people assumed that iron overload and haemochromatosis were synonymous and that iron overload throughout the body defined and caused the clinical disease. Iron overload was determined by liver biopsy, autopsy, and response to therapeutic phlebotomy. In the 1970s, newer blood tests such as serum ferritin and transferrin saturation became part of the diagnostic testing for iron overload.23 In 2005 data from the Hemochromatosis and Iron Overload Screening (HEIRS) Study introduced genetic testing and showed that approximately 57% of female C282Y homozygotes and 20% of male C282Y homozygotes had a normal serum ferritin and/or transferrin saturation without apparent iron overload.4 Transferrin saturation was found to be highly variable within individuals,5 and serum ferritin had mostly false positive results in patients without iron overload. Magnetic resonance imaging became a new tool to assess iron overload in the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.